Request a Test Run
A test run doesn't generate a final report.
It will scan the depth of the output.
We use this phase to validate the available data points specific to your requirements*.
This allows you to see exactly what level of granular, actionable intelligence InsightWise can provide before you commit to a full strategic engagement.
* We will connect with you to collect your strategic requirements for the test run.
See the Full Picture
Discover how Canadian Pharma teams are mapping the Canadian patient, caregiver, and consumer reality, turning fragmented signals into one strategic view your brand team can act on with confidence.
Canadian Pharmaceutical
Intelligence Engine
A comprehensive intelligence report that maps the exact conversational terrain and patient journey for your therapy area.
Get every audience signal that matters:
Data that accounts for two languages and thirteen provincial health systems.
A complete patient journey mapping, with stages and sentiment analysis.
The conversational data around your specific therapy area.
OFFICIAL
LANGUAGES
HEALTH
SYSTEMS
JOURNEY
MAPPING
CANADIAN
DATA
AWARENESS • DIAGNOSIS • TREATMENT • ACCESS • ADHERENCE • OUTCOMES
What is the Value?
Six Intelligence Pillars. One Strategic View.
Built for repositioning, lifecycle strategy, formulary communication, PSP design, advocacy engagement, and every strategic decision where patient behaviour defines the right move.
Check out what clients are saying
We had a mature brand losing share and no clear picture of why. The InsightWise report surfaced a shift in
caregiver sentiment we hadn't seen in our tracking data. It reframed the entire strategy.
Brand Director
Lifecycle Portfolio — Cardiovascular
Amplified
We validate our data capture against your specific parameters before running a full report. This initial test phase ensures a final deliverable that directly answers your strategic questions and aligns with your decision making needs.
Intelligence
The difference between strategic intelligence and surface-level research: the final report is reviewed by senior pharmaceutical strategists before release, and is built exclusively on publicly available sources with full attribution.